Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas

被引:244
作者
Okamoto, Y
Di Patre, PL
Burkhard, C
Horstmann, S
Jourde, B
Fahey, M
Schüler, D
Probst-Hensch, NM
Yasargil, MG
Yonekawa, Y
Lütolf, UM
Kleihues, P
Ohgaki, H
机构
[1] Int Agcy Res Canc, F-69372 Lyon 08, France
[2] Canton Zurich, Canc Registry, CH-8091 Zurich, Switzerland
[3] Coll Med, Dept Neurosurg, Little Rock, AR 72205 USA
[4] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland
[5] Univ Zurich Hosp, Dept Radiol, CH-8091 Zurich, Switzerland
关键词
low-grade diffuse astrocytoma; oligodendroglioma; oligoastrocytoma; population-based study; survival; incidence rate;
D O I
10.1007/s00401-004-0861-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We carried out a population-based study on low-grade diffuse gliomas in the Canton of Zurich, Switzerland (population 1.16 million). From 1980 to 1994, 987 astrocytic and oligodendroglial tumors were diagnosed, of which 122 (12.4%) were low-grade (WHO grade II). The incidence rates adjusted to the World Standard Population, per million population per year, were 2.28 for low-grade diffuse astrocytomas, 0.89 for oligoastrocytomas, and 2.45 for oligodendrogliomas. The survival rate (mean follow-up 7.5+/-4.8 years) was highest for patients with oligodendroglioma (78% at 5 years, 51% at 10 years), followed by those with oligoastrocytoma (70% at 5 years, 49% at 10 years) and fibrillary astrocytoma (65% at 5 years, 31% at 10 years). Survival of patients with gemistocytic astrocytoma was poor, with survival rates of 16% at 5 years and 0% at 10 years. Younger patients (<50 years) survived significantly longer than older patients (>50 years; P=0.013). DNA sequencing, performed in 84% of cases, revealed that TP53 mutations were most frequent in gemistocytic astrocytomas (88%), followed by fibrillary astrocytomas (53%) and oligoastrocytomas (44%), but were infrequent (13%) in oligodendrogliomas. The presence of TP53 mutations was associated with shorter survival of patients with low-grade diffuse gliomas (log-rank test; P=0.047), but when each histological type was analyzed separately, an association was observed only for oligoastrocytoma (P=0.05). Loss on 1p and 19q were assessed by quantitative microsatellite analysis in 67% of cases. These alterations were frequent in oligodendrogliomas (1p, 57%; 19q, 69%), less common in oligoastrocytomas (1p, 27%; 19q, 45%), rare in fibrillary astrocytomas (1p, 7%; 19q, 7%), and absent in gemistocytic astrocytomas. None of these alterations were predictive of survival. These results establish the frequency of key genetic alterations in low-grade diffuse gliomas at a population-based level. Multivariate Cox's regression analysis indicates that only age and histological type, but not genetic alterations, are significant predictive factors.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 37 条
[31]   A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors [J].
Streffer, J ;
Schabet, M ;
Bamberg, M ;
Grote, EH ;
Meyermann, R ;
Voigt, K ;
Dichgans, J ;
Weller, M .
JOURNAL OF NEUROLOGY, 2000, 247 (04) :297-302
[32]   Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy [J].
van den Bent, MJ ;
Kros, JM ;
Heimans, JJ ;
Pronk, LC ;
van Groeningen, CJ ;
Krouwer, HGJ ;
Taphoorn, MJB ;
Zonnenberg, BA ;
Tijssen, CC ;
Twijnstra, A ;
Punt, CJA ;
Boogerd, W .
NEUROLOGY, 1998, 51 (04) :1140-1145
[33]   TREATMENT OF OLIGODENDROGLIOMAS WITH OR WITHOUT POSTOPERATIVE IRRADIATION [J].
WALLNER, KE ;
GONZALES, M ;
SHELINE, GE .
JOURNAL OF NEUROSURGERY, 1988, 68 (05) :684-688
[34]   Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas [J].
Watanabe, K ;
Sato, K ;
Yonekawa, Y ;
Kleihues, P ;
Ohgaki, H .
BRAIN PATHOLOGY, 1996, 6 (03) :217-223
[35]  
Watanabe K, 1997, LAB INVEST, V76, P277
[36]   p53 and PTEN gene mutations in gemistocytic astrocytomas [J].
Watanabe, K ;
Peraud, A ;
Gratas, C ;
Wakai, S ;
Kleihues, P ;
Ohgaki, H .
ACTA NEUROPATHOLOGICA, 1998, 95 (06) :559-564
[37]   Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas [J].
Watanabe, T ;
Nakamura, M ;
Kros, JM ;
Burkhard, C ;
Yonekawa, Y ;
Kleihues, P ;
Ohgaki, H .
ACTA NEUROPATHOLOGICA, 2002, 103 (03) :267-275